Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.38
Trade Value (12mth)
AU$23,723.00
1 week
5.26%
1 month
0%
YTD
-44.44%
1 year
-93.94%
All time high
3.95
EPS 3 yr Growth
-47.70%
EBITDA Margin
-90.00%
Operating Cashflow
-$3m
Free Cash Flow Return
-804.60%
ROIC
-790.10%
Interest Coverage
-5.80
Quick Ratio
0.70
Shares on Issue (Fully Dilluted)
117m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
30 April 25 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
29 April 25 |
Activities Report March 2025 and Appendix 4C
×
Activities Report March 2025 and Appendix 4C |
28 April 25 |
Application for quotation of securities - OSX
×
Application for quotation of securities - OSX |
28 April 25 |
Change in substantial holding
×
Change in substantial holding |
23 April 25 |
Application for quotation of securities - OSX
×
Application for quotation of securities - OSX |
23 April 25 |
Change in substantial holding
×
Change in substantial holding |
17 April 25 |
Change in substantial holding
×
Change in substantial holding |
15 April 25 |
Change in substantial holding
×
Change in substantial holding |
11 April 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
11 April 25 |
Change in substantial holding
×
Change in substantial holding |
11 April 25 |
Change in substantial holding
×
Change in substantial holding |
09 April 25 |
Osteopore secures EU market approvals for custom implants
×
Osteopore secures EU market approvals for custom implants |
09 April 25 |
Notification regarding unquoted securities - OSX
×
Notification regarding unquoted securities - OSX |
09 April 25 |
Application for quotation of securities - OSX
×
Application for quotation of securities - OSX |
08 April 25 |
Reinstatement to Quotation
×
Reinstatement to Quotation |
08 April 25 |
Annual General Meeting Date
×
Annual General Meeting Date |
08 April 25 |
Update - Proposed issue of securities - OSX
×
Update - Proposed issue of securities - OSX |
07 April 25 |
Further Drawdown of T1 of the Redeemable Convertible Notes
×
Further Drawdown of T1 of the Redeemable Convertible Notes |
07 April 25 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
07 April 25 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
01 April 25 |
Annual Report Submission Delayed
×
Annual Report Submission Delayed |
01 April 25 |
Suspension from Quotation
×
Suspension from Quotation |
28 March 25 |
Convertible Note Prospectus
×
Convertible Note Prospectus |
28 March 25 |
Proposed issue of securities - OSX
×
Proposed issue of securities - OSX |
25 March 25 |
OSX opens knee preservation centre of excellence
×
OSX opens knee preservation centre of excellence |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.